Ocular Hypertension
516
22
30
400
Key Insights
Highlights
Success Rate
95% trial completion (above average)
Published Results
186 trials with published results (36%)
Research Maturity
400 completed trials (78% of total)
Clinical Risk Assessment
Based on trial outcomes
Low Risk
Score: 17/100
4.3%
22 terminated out of 516 trials
94.8%
+8.3% vs benchmark
46%
239 trials in Phase 3/4
47%
186 of 400 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 400 completed trials
Clinical Trials (516)
Comparative Study of the Efficacy of Either Krytantek Ofteno PF® or Eliptic Ofteno PF® Plus Gaap Ofteno PF® for POAG or Ocular Hypertension.
24-hour Effect of Rocklatan Compared With Latanoprost in Open Angle Glaucoma and Ocular Hypertension Patients
Intraocular Pressure Measured by a Novel Sensing Contact Lens Versus Tonometry
Reformulated PG324 Ophthalmic Solution for Intraocular Pressure Reduction
DSLT for Reducing Medication in Glaucoma
24-hour Wear Performance and Safety Study of Smartlens miLens Contact Lens for IOP Monitoring
AGN-193408 SR in the Treatment of Open-angle Glaucoma or Ocular Hypertension
Biomarkers of Ocular Surface Damage in the Setting of Topical Ocular Hypotensive Medication Use
Efficacy of the Nanodropper Device on Intraocular Pressure in Patients With Glaucoma
Ph2 Placebo-Controlled Study for Safety & Ocular Efficacy of SBI-100 Ophthalmic Emulsion in Pts w/ Elevated Eye Pressure
Efficacy and Safety of HUC3-637 in Patients With Primary Open Angle Glaucoma or Ocular Hypertension
Efficacy and Safety Assessment of T4090 Ophthalmic Solution Versus Rhopressa® Ophthalmic Solution in Patients With Open-angle Glaucoma or Ocular Hypertension
Implementing AI-based Glaucoma Screening Within Federally Qualified Health Centers
Direct Selective Laser Trabeculoplasty in Ethnic Chinese Population
Next Generation Rocklatan
Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhine)
Evaluation of the Safety and Efficacy of the Bimatoprost Implant System Used in Combination With the SpyGlass IOL Compared to Timolol Ophthalmic Solution (Rhone)
Latanoprost Eluting Contact Lens for Treating Glaucoma and Ocular Hypertension
GLAUcoma Diagnostic and Imaging Analysis (GLAUDIA) Study
Optimal Treatment Protocol for Selective Laser Trabeculoplasty